178 related articles for article (PubMed ID: 10962564)
21. Repression of transactivation of the retinoic acid receptor beta2 promoter in human breast cancer cells.
Tsou HC; Yao YJ; Xie XX; Ping XL; Peacocke M
Exp Cell Res; 1998 Nov; 245(1):221-7. PubMed ID: 9828119
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth.
Li XS; Shao ZM; Sheikh MS; Eiseman JL; Sentz D; Jetten AM; Chen JC; Dawson MI; Aisner S; Rishi AK
J Cell Physiol; 1995 Dec; 165(3):449-58. PubMed ID: 7593223
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
[TBL] [Abstract][Full Text] [Related]
26. The promoter context is a decisive factor in establishing selective responsiveness to nuclear class II receptors.
Sanguedolce MV; Leblanc BP; Betz JL; Stunnenberg HG
EMBO J; 1997 May; 16(10):2861-73. PubMed ID: 9184230
[TBL] [Abstract][Full Text] [Related]
27. Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells.
Stefanska B; Rudnicka K; Bednarek A; Fabianowska-Majewska K
Eur J Pharmacol; 2010 Jul; 638(1-3):47-53. PubMed ID: 20447390
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression.
Kusui C; Kimura T; Ogita K; Nakamura H; Matsumura Y; Koyama M; Azuma C; Murata Y
Biochem Biophys Res Commun; 2001 Dec; 289(3):681-6. PubMed ID: 11726201
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer.
Esteller M; Guo M; Moreno V; Peinado MA; Capella G; Galm O; Baylin SB; Herman JG
Cancer Res; 2002 Oct; 62(20):5902-5. PubMed ID: 12384555
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
32. Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region.
Li A; Zhu X; Craft CM
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1375-83. PubMed ID: 11980849
[TBL] [Abstract][Full Text] [Related]
33. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
34. The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells.
Jing Y; Waxman S; Mira-y-Lopez R
Cancer Res; 1997 May; 57(9):1668-72. PubMed ID: 9135005
[TBL] [Abstract][Full Text] [Related]
35. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.
Pirouzpanah S; Taleban FA; Atri M; Abadi AR; Mehdipour P
Cancer Causes Control; 2010 Dec; 21(12):2101-11. PubMed ID: 20711807
[TBL] [Abstract][Full Text] [Related]
36. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
Manjegowda MC; Gupta PS; Limaye AM
Gene; 2017 May; 614():65-73. PubMed ID: 28286086
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
38. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
[TBL] [Abstract][Full Text] [Related]
39. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.
Di Croce L; Raker VA; Corsaro M; Fazi F; Fanelli M; Faretta M; Fuks F; Lo Coco F; Kouzarides T; Nervi C; Minucci S; Pelicci PG
Science; 2002 Feb; 295(5557):1079-82. PubMed ID: 11834837
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer.
Hayashi K; Yokozaki H; Goodison S; Oue N; Suzuki T; Lotan R; Yasui W; Tahara E
Differentiation; 2001 Aug; 68(1):13-21. PubMed ID: 11683489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
